Sangamo Therapeutics, Inc. (SGMOQ)
0.1102
-0.03
(-21.79%)
USD |
OTCM |
Oct 16, 16:00
Sangamo Therapeutics Net Income (TTM) : -123.33M for March 31, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -123.33M |
| December 31, 2025 | -122.93M |
| September 30, 2025 | -108.91M |
| June 30, 2025 | -64.59M |
| March 31, 2025 | -80.74M |
| December 31, 2024 | -99.23M |
| September 30, 2024 | -136.13M |
| June 30, 2024 | -249.68M |
| March 31, 2024 | -328.05M |
| December 31, 2023 | -257.83M |
| September 30, 2023 | -249.51M |
| June 30, 2023 | -198.50M |
| March 31, 2023 | -127.17M |
| December 31, 2022 | -192.28M |
| September 30, 2022 | -177.80M |
| June 30, 2022 | -172.33M |
| March 31, 2022 | -176.34M |
| December 31, 2021 | -178.30M |
| September 30, 2021 | -181.48M |
| June 30, 2021 | -135.30M |
| March 31, 2021 | -124.09M |
| December 31, 2020 | -121.12M |
| September 30, 2020 | -75.95M |
| June 30, 2020 | -101.80M |
| March 31, 2020 | -96.19M |
| Date | Value |
|---|---|
| December 31, 2019 | -95.42M |
| September 30, 2019 | -119.14M |
| June 30, 2019 | -104.62M |
| March 31, 2019 | -90.90M |
| December 31, 2018 | -68.89M |
| September 30, 2018 | -62.76M |
| June 30, 2018 | -62.27M |
| March 31, 2018 | -58.12M |
| December 31, 2017 | -54.57M |
| September 30, 2017 | -51.10M |
| June 30, 2017 | -57.71M |
| March 31, 2017 | -71.80M |
| December 31, 2016 | -71.66M |
| September 30, 2016 | -76.05M |
| June 30, 2016 | -66.33M |
| March 31, 2016 | -51.88M |
| December 31, 2015 | -40.70M |
| September 30, 2015 | -31.01M |
| June 30, 2015 | -29.31M |
| March 31, 2015 | -24.16M |
| December 31, 2014 | -26.42M |
| September 30, 2014 | -30.24M |
| June 30, 2014 | -28.84M |
| March 31, 2014 | -27.31M |
| December 31, 2013 | -26.62M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.47M |
| Vicapsys Life Sciences, Inc. | -0.7586M |